SLDB:NASDAQSolid Biosciences Inc. Analysis
Data as of 2026-09-01 - not real-time
$9.65
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Solid Biosciences Inc. trades at $9.64, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 14.0%. With RSI at 56.2 the momentum picture is neutral, alongside a bullish MACD signal. Watch $8.29 as support and $10.27 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 93.5% above today's level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 56.6%, a beta of 2.05 and a maximum drawdown of 38.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 93.5% above today's level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 56.6%, a beta of 2.05 and a maximum drawdown of 38.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 1 out of 10.
Top Market Events
- Duchenne SGT-003 : SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with...Detailed price information for Solid Biosciences Inc SLDB-Q from The Globe and Mail including charting and trades.Yahoo Finance25dSolid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business UpdatesThe above...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 7.22
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 7.22
- Analyst targets imply +93.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +93.5% versus the current price
- Negative return on equity of -65.5%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-5.5
ROE-65.50%
ROA-36.38%
Debt/Equity5.39
P/B Ratio2.7
Op. Cash Flow$-186844000
Free Cash Flow$-118235624
Industry P/E30.6
Technical Analysis
TrendBullish
RSI56.2
Support$8.29
Resistance$10.27
MA 20$9.24
MA 50$9.22
MA 200$7.22
MACDBullish
VolumeStable
Fear & Greed Index94.09
Valuation
Target Price$18.67
Upside/Downside93.54%
GradeFair
TypeBlend
Risk Assessment
Beta2.05
Volatility56.60%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.